表紙
市場調查報告書

兒童用藥物及疫苗的全球市場

Pediatric Drugs and Vaccines

出版商 Global Industry Analysts, Inc. 商品編碼 243089
出版日期 內容資訊 英文 170 Pages
商品交期: 最快1-2個工作天內
價格
兒童用藥物及疫苗的全球市場 Pediatric Drugs and Vaccines
出版日期: 2020年02月01日內容資訊: 英文 170 Pages
簡介

本報告提供全球兒童用醫藥品·疫苗的市場調查,彙整產業背景,主要趨勢,市場的各種影響因素分析,兒童疾病概要·統計·治療,產品的銷售·核准趨勢,企業及企業間的配合措施,主要企業簡介,各區各國的市場成長預測等資料。

第1章 簡介·調查手法·產品定義

第2章 摘要整理

  • 產業概要
    • 小兒科:一個高度低估的部門
    • 兒童用醫藥品市場:市場機會的存在
    • 美國:最大的市場
    • 新興市場:展現急速成長
    • 抗生劑:最大銷售額的藥物類別
    • 兒童用疫苗市場:高增長的軌道
    • 供需動態
    • 聯合國兒童基金會處理BCG疫苗供應短缺問題
  • 成長推進因素·市場趨勢
    • 新產品的認證·開發平台
    • 兒童用醫藥品的認證趨勢
    • 第三階段以後的兒童用醫藥品
    • 肥胖相關症狀的兒童用醫藥品的潛在性
    • 血性心臟衰竭治療的兒童用醫藥品的清單
    • 兒童用醫藥品開發的課題
    • 建模&模擬
    • 疫苗開發
    • 兒童用罕見疾病用醫藥品等
  • 兒童用疫苗市場
    • 疫苗接種的對象
    • 主要疫苗製造商的市場佔有率
    • 第三階段以後的兒童用疫苗
    • 兒童用疫苗的各種類型等
  • 兒童疾病:概要·統計·治療
    • 流感
    • 泌尿道感染
    • 腮腺炎
    • 念珠菌感染
    • 傳染性紅斑
    • 傳染性軟屬腫
    • 玫瑰疹
    • 破傷風
    • 百日咳
    • 過敏·呼吸系統疾病
    • 白喉
    • 麻疹
    • 氣喘等
  • 主要的FDA核準兒童用醫藥品的清單
  • 產品的銷售·核准
    • Actelion
    • Merck KEYTRUDA®
    • Novartis
    • Boehringer Ingelheim Tiotropium Respimat®
    • Sanofi Pasteur
    • ViiV Healthcare
    • Shire ADYNOVATE®
    • Pfizer Inc.
    • Simponi®
    • Novo Nordisk NovoRapid®等
  • 企業間的配合措施
    • Johnson & Johnson·Actelion
    • Sanofi·MedImmune
    • GSK
    • Lupin·Monosol Rx
    • ICGEB & Sun Pharma
    • Actelion
    • Shire·Cincinnati Children's等
  • 主要企業
  • 全球市場的展望

第3章 地區市場分析

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 其他
  • 南美
  • 其他地區

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6503

Pediatric Drugs and Vaccines market worldwide is projected to grow by US$53.6 Billion, driven by a compounded growth of 6.7%. Antibiotics, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$36.3 Billion by the year 2025, Antibiotics will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 5.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.9 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.6 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Antibiotics will reach a market size of US$1.3 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.9% over the next couple of years and add approximately US$14.7 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Allergan Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Genentech Inc.
  • GlaxoSmithKline Plc.
  • Janssen Biologics B.V
  • Merck & Co. Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi
  • Shionogi Inc.
  • Shire Pharmaceuticals Group Plc

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Pediatrics: A Highly Underserved and Undervalued Group
  • Recent Market Activity
  • Pediatric Drugs Market - An Abode of Opportunities
  • The United States: Largest Market for Pediatric Drugs and Vaccines
  • Developing Markets to Witness Faster Growth
  • Antibiotics: Largest Selling Drug Classes
  • Pediatric Vaccines Market - On High Growth Trajectory
  • Supply and Demand Dynamics of the Global Vaccine Market
  • UNICEF Addresses BCG Vaccine Supply Shortage
  • Access to Vaccines Index: Aiding Increased Access to Vaccines
  • Recent Advancements/Achievements in the Pediatric Vaccines Space
  • Global Competitor Market Shares
  • Pediatric Drugs and Vaccines Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

  • Abbott Laboratories (USA)
  • Allergan, Inc. (USA)
  • Amgen, Inc. (USA)
  • AstraZeneca Plc. (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • Bristol-Myers Squibb Company (USA)
  • Eli Lilly and Company (USA)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Genentech, Inc. (USA)
  • GlaxoSmithKline plc. (UK)
  • Janssen Biologics B.V. (USA)
  • Actelion Pharmaceuticals Ltd (Switzerland) (A Janssen Pharmaceutical Company)
  • Merck & Co., Inc. (USA)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Pfizer, Inc. (USA)
  • Sanofi S.A (France)
  • Shionogi Inc. (USA)
  • Shire Pharmaceuticals Group Plc. (UK)

3. MARKET TRENDS & DRIVERS

  • Pediatric Exclusivity Drives Manufacturers' Interest
  • Pediatric Exclusitivity Granted to Branded Drugs
  • New Product Approvals and Pipeline - A Key Growth Propeller
  • Recent Pediatric Drug Approvals: 2015-2017
  • Pediatric Drug Approvals: 2011-2014
  • Phase III Completed Pediatric Drugs: 2015-2017 (As of July 2017)
  • Ongoing Phase III Pediatric Drugs Clinical Trials: 2015-2017 (As of July 2017)
  • Potential for Pediatric Drugs Against Obesity-related Conditions
  • List of Pediatric Drugs for Congestive Heart Failure Treatment
  • Recent Findings to Help Save Children's Lives
  • Challenges of Pediatric Drug Development: Formulation Problems and Ethical Constraints of Clinical Trials
  • Financial Enticement for Drug Makers to Conduct Dedicated Pediatric Trials
  • Modeling & Simulation - A Powerful Tool for Pediatric Clinical Study Sponsors
  • Pharmacometrics Approaches Gain Traction Among US and EU Researchers
  • Challenges Associated with Adoption of Pharmacometric Approach
  • Guidelines for Conducting Ethically Correct Clinical Trials
  • Pediatric Drug Market - Is Off-label Prescription Justified?
  • Indian Drug Manufacturers Develop Pneumococcal Conjugate Vaccine
  • High Vaccination Costs: A Major Hindrance for Pneumonia Vaccination
  • Vaccine Refusal by Parents - A Growing Trend in the US Market
  • Orphan Drugs for Pediatric Use Gain Popularity
  • List of FDA Approved Orphan Drugs: 2015-2016
  • List of FDA Designated Orphan Drugs: 2015-2017
  • Pediatric Review Vouchers Foster Innovation in Rare Pediatric Drugs
  • Need for Higher Focus on Fixed-Dose Combination for Pediatric HIV Infections
  • Approved Pediatric Antiretroviral Drugs for HIV Treatment
  • Highly Fragmented Growth Hormone Market

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Pediatric Drugs and Vaccines Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Pediatric Drugs and Vaccines Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Pediatric Drugs and Vaccines Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Antibiotics (Therapeutic Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Antibiotics (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Antibiotics (Therapeutic Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Vaccines (Therapeutic Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Vaccines (Therapeutic Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Vaccines (Therapeutic Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Allergy & Respiratory (Therapeutic Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Allergy & Respiratory (Therapeutic Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Allergy & Respiratory (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: CNS (Therapeutic Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: CNS (Therapeutic Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: CNS (Therapeutic Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Hormones (Therapeutic Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Hormones (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Hormones (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Other Therapeutic Classes (Therapeutic Class) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Other Therapeutic Classes (Therapeutic Class) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Other Therapeutic Classes (Therapeutic Class) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Pediatric Drugs and Vaccines Market Share (in %) by Company: 2020 & 2025
    • Market Analytics
    • TABLE 22: United States Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 23: Pediatric Drugs and Vaccines Market in the United States by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 24: United States Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 25: Canadian Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 26: Canadian Pediatric Drugs and Vaccines Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 27: Pediatric Drugs and Vaccines Market in Canada: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
  • JAPAN
    • TABLE 28: Japanese Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 29: Pediatric Drugs and Vaccines Market in Japan: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 30: Japanese Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 31: Chinese Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 32: Pediatric Drugs and Vaccines Historic Market Analysis in China in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 33: Chinese Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Pediatric Drugs and Vaccines Market: Competitor Market Share Scenario (in %) for 2020 & 2025
    • Market Analytics
    • TABLE 34: European Pediatric Drugs and Vaccines Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 35: Pediatric Drugs and Vaccines Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 36: European Pediatric Drugs and Vaccines Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 37: European Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 38: Pediatric Drugs and Vaccines Market in Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 39: European Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 40: Pediatric Drugs and Vaccines Market in France by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 41: French Pediatric Drugs and Vaccines Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 42: French Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 43: Pediatric Drugs and Vaccines Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 44: German Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 45: German Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 46: Italian Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 47: Pediatric Drugs and Vaccines Historic Market Analysis in Italy in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 48: Italian Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 50: Pediatric Drugs and Vaccines Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 51: United Kingdom Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 52: Spanish Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 53: Spanish Pediatric Drugs and Vaccines Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 54: Pediatric Drugs and Vaccines Market in Spain: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 55: Russian Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 56: Pediatric Drugs and Vaccines Market in Russia by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 57: Russian Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 59: Pediatric Drugs and Vaccines Market in Rest of Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 60: Rest of Europe Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 61: Asia-Pacific Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 62: Pediatric Drugs and Vaccines Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 63: Asia-Pacific Pediatric Drugs and Vaccines Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 64: Pediatric Drugs and Vaccines Market in Asia-Pacific by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 65: Asia-Pacific Pediatric Drugs and Vaccines Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 66: Asia-Pacific Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 67: Pediatric Drugs and Vaccines Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 68: Australian Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 69: Australian Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 70: Indian Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 71: Indian Pediatric Drugs and Vaccines Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 72: Pediatric Drugs and Vaccines Market in India: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 73: Pediatric Drugs and Vaccines Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 74: South Korean Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 75: Pediatric Drugs and Vaccines Market Share Distribution in South Korea by Therapeutic Class: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 76: Rest of Asia-Pacific Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 77: Pediatric Drugs and Vaccines Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 78: Rest of Asia-Pacific Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 79: Latin American Pediatric Drugs and Vaccines Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 80: Pediatric Drugs and Vaccines Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 81: Latin American Pediatric Drugs and Vaccines Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 82: Latin American Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 83: Pediatric Drugs and Vaccines Historic Market Analysis in Latin America in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 84: Latin American Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 85: Argentinean Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 86: Pediatric Drugs and Vaccines Market in Argentina in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 87: Argentinean Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 88: Pediatric Drugs and Vaccines Market in Brazil by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 89: Brazilian Pediatric Drugs and Vaccines Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 90: Brazilian Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 91: Pediatric Drugs and Vaccines Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 92: Mexican Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 93: Mexican Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 94: Rest of Latin America Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 95: Pediatric Drugs and Vaccines Market in Rest of Latin America by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 96: Rest of Latin America Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 97: The Middle East Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 98: Pediatric Drugs and Vaccines Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 99: The Middle East Pediatric Drugs and Vaccines Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 100: The Middle East Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 101: The Middle East Pediatric Drugs and Vaccines Historic Market by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 102: Pediatric Drugs and Vaccines Market in the Middle East: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
  • IRAN
    • TABLE 103: Iranian Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 104: Pediatric Drugs and Vaccines Market in Iran: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 105: Iranian Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 106: Israeli Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 107: Pediatric Drugs and Vaccines Market in Israel in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 108: Israeli Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 109: Saudi Arabian Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 110: Pediatric Drugs and Vaccines Historic Market Analysis in Saudi Arabia in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 111: Saudi Arabian Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 112: Pediatric Drugs and Vaccines Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 113: United Arab Emirates Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 114: Pediatric Drugs and Vaccines Market Share Distribution in United Arab Emirates by Therapeutic Class: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 115: Pediatric Drugs and Vaccines Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 116: Rest of Middle East Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 117: Rest of Middle East Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 118: African Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 119: Pediatric Drugs and Vaccines Market in Africa by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 120: African Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025

IV. COMPETITION

  • Total Companies Profiled: 90
  • PEDIATRIC DRUGS AND VACCINES MCP-6503
  • CONTENTS